Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 07, 2016 FBO #5340
SOLICITATION NOTICE

68 -- Human Sera Reference Panel

Notice Date
7/5/2016
 
Notice Type
Presolicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2016-99858
 
Archive Date
7/25/2016
 
Point of Contact
David S Dombeck, Phone: 7704882695
 
E-Mail Address
ddombeck@cdc.gov
(ddombeck@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
The Centers for Disease Control and Prevention, NCIRD/DVD, 1600 Clifton Rd. NE, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract in accordance with FAR 6.302-1 to Access Biologicals, LLC, 995 Park Center Drive, Vista, CA 92081 to acquire additional Human Sera Reference Panels for Validation of Laboratory Developed Serologic Tests as Controls for Diagnostic Tests. The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 6.302-1, "Logical Follow-on." The National Center for Immunization and Respiratory Disease has a requirement for the purchase of additional Human Sera Reference Panels to continue extensive avidity testing on a large number of measles IgG positive sera. The Measles IgG positive sera has already been tested using the Sera from Access Biologicals, and additional sera is required to complete the testing with minimal change in the controls. Further, if an alternative source for the sera were selected additional testing at great expense and inefficiency would be required to determine if the new sera is suitable for use in the laboratory and for the continued testing of the Measles IgG. Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 5 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency. Please forward the capability statement and/or pricing information to David Dombeck, Contract Officer, Reference 2015-80812, Centers for Disease Control, Procurement and Grants Office, ATTN: David Dombeck, MS: K-14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov. The Government will review any/all capabilities statements and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received within 5 days, negotiations will be conducted with Access Biologicals, LLC, as the only source and a contract will be issued without any additional notices being posted.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-99858/listing.html)
 
Place of Performance
Address: 1600 Clifton Road, Atlanta, Georgia, 30329, United States
Zip Code: 30329
 
Record
SN04171785-W 20160707/160705235026-9358a89b0847f69b38a7939c6a384d54 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.